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The factors responsible for the conjunctivitis and iritis associated with acute ocular infection and post
enteric inﬂammatory disease are not fully known. The pro-inﬂammatory activity of unilateral topical
application of muramyl dipeptide (MDP; the smallest bio-active Gram-positive and Gram-negative
bacterial cell wall component) was investigated in adult rabbits. The resultant bilateral conjunctivitis/
iritis and pyogenic responses were characterized. Bilateral symptoms were graded by slit lamp exami-
nations; tear ﬂuid, Schirmer tests (tear production), blood and aqueous humor (AH) samples were ob-
tained from MDP-treated and untreated rabbits. MDP concentration, gamma-glutamyltranspeptidase
activity (GGT; key enzyme in glutathione recapture, xenobiotic detoxiﬁcation, eicosanoid synthesis and
neutrophil function), protein concentration, and tear cell density, cytology, and immunoﬂuorescent
antibody reactivity to GGT and calreticulin (CRT; MDP-binding protein) were determined. MDP was
cleared from ipsilateral tears and serum by 6 h, but was undetected in mock-treated contralateral tears.
Bilateral signs of acute transient pyogenic conjunctivitis, characterized by tearing, lid edema, conjunctival
hyperemia, chemosis and leukocytic inﬁltrate with iritis (erythema and aqueous ﬂare) were detected.
Milder symptoms occurred in the mock-treated contralateral eyes. Bilateral symptoms, tear production,
tear protein, GGT activity, and mucopurulent discharge (containing up to 2.5e5.0  106 cells/mL) were
elevated 4e8 h post MDP and resolved to near pre-treatment levels by 24 h. Tear GGT activity and protein
levels were higher in MDP-treated and mock-treated contralateral eyes than in eyes of untreated adult
rabbits (p’s < 0.001). Elevated tear GGT activity was associated with histopathology and increased
vascular and epithelial permeability to serum protein, GGT-positive epithelia cells, macrophages and
heterophils. Repeat MDP applications induced recurrent induction and resolution patterns of bilateral
conjunctivitis/iritis and tear GGT activity, but ipsilateral GGT responses were lower. The results suggest
unilateral topical MDP application to adult rabbit eyes induces a bilateral acute pyogenic conjunctivitis/
iritis (PCI) characterized by increased vascular and epithelial permeability similar to acute bacterial
conjunctivitis in man. The detection of CRT/GGT positive heterophils in tears suggests efferocytosis
(phagocytosis of dead/dying cells). Tear GGT activity may be a useful means to quantify MDP-induced
toxicity and extraocular inﬂammation.
 2013 The Authors. Published by Elsevier Ltd. Open access under CC BY-NC-SA license.ueous barrier; BCB, blood-conjunctival-barrier; BTB, blood-tear-barrier; CD50, 50% cytotoxic dose; CRT, calreticulin; GGT,
; MDP, muramyl dipeptide; TNF-a, tumor necrosis factor-a.
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Bacterial overgrowth at the external ocular surface usually in-
duces an inﬂammatory response involving the eyelids (blepharitis),
conjunctiva (conjunctivitis), cornea (keratitis) and/or iris (iritis). In
addition, bilateral conjunctivitis and/or iritis can be associated with
focal infections (Benedict, 1921), Reiter’s syndrome, enteric artro-
pathies (Ford, 1979), inﬂammatory bowel disease (Geerards et al.,
1997), and intravesical injection of Bacille de Calmette et Guérin
(BCG) vaccine (Murata et al., 2004). Most bacteria-positive acute
conjunctivitis presents as an abrupt onset, unilateral or bilateral,
cornea-sparing inﬂammation with or without mucoid or muco-
purulent discharge that resolves in 2e5 days without sequelae
(Syed and Chandler, 1995). Pyogenic bacterial conjunctivitis is
characterized by mucopurulent tear, containing plasma proteins
and leukocytes, causing adhesion of the eyelids and/or crusty
eyelashes. Topical application of bacteria alone does not produce
conjunctivitis (Behrens-Baumann and Begall, 1993). Current bac-
teria conjunctivitis/iritis models rely on injection (Liang et al.,
2006; McCormick et al., 2011; Oka et al., 2004; Sloop et al., 1999)
or topical application of bacteria or lipopolysaccharide (LPS) to
abraded cornea (Schultz et al., 1997).
Degraded and phagocytic cell digested Gram-positive and Gram-
negative bacteria release muramyl dipeptide (MDP; N-acetyl-mur-
amyl-L-alanyl-D-isoglutamine) (Johannsen et al., 1991). MDP is the
smallest component of bacterial cell wall peptidoglycan (Chang et al.,
1981) with multiple, dose-dependent, stereo-isomer speciﬁc bio-
logically activities (Adam et al., 1981; Cottagnoud et al., 2003; Kotani
et al.,1986; Langford et al., 2002), including potent pro-inﬂammatory,
edemagenic, somnogenic, pyrogenic, immunostimulatory (Adam
et al., 1981; Chang et al., 1981; Fox et al., 1984; Johannsen et al.,
1991; Kotani et al., 1976, 1986; Langford et al., 2006; Oppenheim
et al., 1980), and calreticulin (CRT)-dependent cytotoxicity (Chen
et al., 2005; Langford et al., 2006). Topical MDP application has
been shown to increase protein and immunoglobulins in tears of
rabbits immunized with poliovirus vaccine in Freund’s complete
adjuvant (Langford et al., 2003). However, MDP-induced activities
have not been assessed in rabbit conjunctival tissue.
The innate immune response to infection represented by
inﬂammation and inﬁltrating leukocytes plays an essential role in
clearing bacteria. Gamma-glutamyltranspeptidase (GGT; for review
see Lieberman et al., 1995) is expressed on inﬁltrating neutrophils
(Brom et al., 1984), monocytes (Grisk et al., 1993) and T cells
(Carlisle et al., 2003). GGT activity plays a key role in maintaining
glutathione (Jensen and Meister, 1983), leukotriene and prosta-
glandin synthesis (Black et al., 1994; Shimizu andWolfe, 1990), and
neutrophil function (Kobayashi et al., 2003). GGT activity has been
used as a parameter of the inﬂammatory response in cystic ﬁbrosis
(Corti et al., 2012), arthritic (Singh et al., 1986), diabetic (Langford
et al., 2007), hepatic (Tahan et al., 2008), and cardiac disease
(Mason et al., 2010). Interestingly, tear GGT activity is elevated in
eyes of individuals with refraction errors and >40 years of age
(Calderón de la Barca Gázquez et al., 1989), but reduced in diabetic
individuals (Burnham et al., 2013). MDP has been shown to
decrease GGT activity in vitro and in vivo (Langford et al., 1999,
2002). The levels of GGT activity in tears during ocular inﬂamma-
tion are unknown.
This paper presents the induction of bilateral pyogenic
conjunctivitis with iritis (PCI) in adult rabbits following topical
unilateral MDP application, the rapid removal of MDP from tear and
serum, the bilateral tear GGT levels over the course of the inﬂam-
mation, and the characterization of the leukocytic inﬁltrate. Single
and multiple unilateral topical MDP applications induced bilateral
transient, acute conjunctivitis with chemosis, iritis, increased tear
GGT activity and mucopurulent discharge predominantlycomposed of GGT-positive macrophages and heterophils (neutro-
phils). Some heterophils expressed CRT on their surface indicative
of efferocytosis [the removal of dying/dead cells by phagocytic
cells] (Thorp et al., 2011). The results suggest the bilateral PCI
induced by MDP is due to cytotoxic and immunomodulatory ac-
tivities produced in the ipsilateral eye that contribute to an innate
consensual response in the fellow eye. The results support the
resilience of the adult rabbit conjunctiva and iris to repeat topical
MDP application.
2. Materials and methods
2.1. Experimental procedure
Adult New ZealandWhite male and female rabbits (2e5 yrs-old,
4.0e5.5 kg; Myrtle Rabbitry (Thompson Station, TN)) were accli-
mated and maintained in an environmentally controlled animal
care facility (22  2 C; 12 h/12 h light/dark cycle). Venous blood
(1e2 mL) and tear samples were collected prior to and at times
indicated through 48 h after the unilateral topical application of the
MDP [50 mg/100 ml; w10,000 rabbit kidney cell cytotoxic doses
(Langford et al., 2002) (Sigma Scientiﬁc, St. Louis, MO)] in lubricant
eye drops (Optive; Allergan, Inc., Irvine, CA). The MDP and mock
eye drop solutions were applied drop-wise onto the superior
palpebral and bulbar conjunctiva of unanesthetized eyes of each
test rabbit, while only eye drops were applied to the eyes of un-
treated control rabbits. The lacrimal ducts were gently occluded for
5min. Tear, blood, post mortem AH and conjunctival tissue samples
were collected at times post treatment and processed for analysis
(see below). Three normal cohort untreated adult rabbits were
evaluated for tear production by Schirmer tests and provided
control tear over a 24 h period, blood, post mortem aqueous humor
(AH), and tissue samples.
To investigate the effects of repeat MDP challenges, 6 identical
MDP doses were applied at 3e5 day intervals over a 16 d period to
the same eyes of 3 rabbits. The bilateral symptoms and tear GGT
activities on Schirmer test strips were assessed at 0, 2, 4, 6, 8, 24 and
48 h after each application. Rabbits were housed in an accredited
LSUHSC animal care facility and cared for by certiﬁed animal care
personnel. IACUC approved experiments and euthanasia pro-
cedures were performed in accordance with the recommendations
of the Guide for the Care and Use of Laboratory Animals (Institute of
Laboratory Animal Resources) and the Public Health Service Policy
on Humane Care and Use of Laboratory Animals.
2.2. Slit lamp examination
Bilateral external ocular and slit lamp examinations were per-
formed through the 48 h post-application period on each rabbit
using a Carl Zeiss slit lamp biomicroscope (NAG f Oph-Leu 309620;
West Germany), representative photos were taken, clinical symp-
toms scored hourly using a modiﬁed “inﬂammatory score” system
similar to that previously reported by others (Fox et al., 1984;
McCormick et al., 2011). Brieﬂy, four clinical symptoms (hyper-
emia, conjunctival chemosis, exudate and iritis) were scored at each
time point by one grader (MPL) using a scale of 0e3; i.e., a score of
0 (absence of symptom), 1 (detectable), 2 (intermediate) or 3
(maximal). The sum of average scores for each eye at each time
point for 6 rabbits was plotted to generate the clinical course of the
bilateral ocular inﬂammatory response.
2.3. Tear, blood, AH, and conjunctival tissue samples
Bilateral tear samples were collected over a 5e15 min period by
2 lab personnel using disposable 20 ml borosilicate glass capillary
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described (Langford et al., 1986). Five microliters of each tear
sample were pipetted onto glass slides and air-dried (for cytology).
The remaining tear was centrifuged (3000  g for 5 min). The
clariﬁed tear ﬂuid was stored frozen (20 C) in a labeled vial until
assayed for GGT activity and protein. Blood samples (0.5e2 mL)
were obtained via ear venipuncture using a 5 cc syringe ﬁtted with
a 25-gauge infusion needle (Smiths Medical ASD, Inc., Keene, NH).
The serum was collected from clotted blood post centrifugation
(2000  g for 3 min) and stored at 20 C. Post mortem AH and
conjunctival tissue samples were collected as previously described
(Langford et al., 1999, 2006). Conjunctival tissue samples from the
MDP-treated and mock-treated control eyes of euthanized rabbits
were rinsed gently in 1 mL of cold phosphate buffered saline (PBS;
pH 7.4), placed in a plastic embedding trays containing Tissue Tek
O.C.T. compound (Miles, Inc., Elkhart, IN) and frozen at 100 C.
2.4. MDP quantiﬁcation
MDP was quantiﬁed in thawed tear ﬂuids and sera collected at
times post unilateral topical MDP application as previously
described (Langford et al., 2002). The 50% cytotoxic dose (CD50)/
tear and serum sample was determined in triplicate bioassays and
the mean CD50/mL (standard error of the mean, SEM)/time point/
rabbit group was calculated.
2.5. Tear production
Bilateral tear production was determined by Schirmer tests
(Clement Clarke International, Harlow, Essex, UK) (Wright and
Meger, 1962). Tear production (mm/5 min) was determined at
each time point for untreated control (eye-drops only), MDP-
treated and mock-treated contralateral rabbit eyes. The mean
(SD; standard deviation) was calculated for each rabbit group. The
Schirmer tear test strips were air-dried and assayed for GGT activity
and protein (see below).
2.6. GGT assay
Tear ﬂuid, serum and post mortem AH samples were assayed for
GGT as described previously (Burnham et al., 2013; Langford et al.,
1999, 2007). Air-dried Schirmer tear test strips were placed in 1 mL
of assay medium and incubated at room temperature for 3 h. One
unit (U) of GGT activity represents conversion of 1.0 nM of g-glu-
tamyl-para-nitroanalide. The levels of tear, serum, and post mor-
tem AH GGT activity were expressed as U/mL. Schirmer tear test
strip GGT activity was expressed as U/strip.
2.7. Tear protein quantiﬁcation and gel analyses
The concentrations of protein in tear ﬂuid and AH and adsorbed
to Schirmer test strips were determined by colorimetric protein
assay (Bio-Rad Protein Assay, Bio-Rad Laboratories, Hercules, CA)
using bovine albumin as standard (1 mg/mL; Sigma) (Langford
et al., 2002). Tear and AH protein proﬁles were demonstrated by
SDS-polyacrylamide gel electrophoresis (PAGE) as previously re-
ported (Chen et al., 2005; Langford et al., 1999). Protein bands were
stained with GelCode Blue Stain Reagent (Pierce, Rockford, IL:
www.piercenet.com) as per the manufacturer’s instructions.
2.8. Tear cells and conjunctival histology
The tear cell densities (number of cells/mL) for bilateral tears
collected over 24 h from 4 MDP-treated rabbits were determined
using a Bright Line hemocytometer per the manufacturer’sinstructions (Reichert Scientiﬁc Instruments, Buffalo, NY). Bilateral
tears collected in glass capillary tubes were pipetted onto glass
slides (5 ml/drop/slide), air-dried at room temperature and stored at
4 C. The air-dried cells were ﬁxed with cold 70% ethanol or acetone
(4 C for 15 min) and rinsed 4 times with cold PBS. Similarly, serial
cryostat conjunctival tissue sections were cut (2e3 sections placed/
5 slides), air-dried, ﬁxed with cold 70% ethanol and stored at 4 C.
Air-dried tear samples, ethanol or acetone ﬁxed conjunctival
cryostat-sections and parafﬁn-embedded formalin-ﬁxed tissue
sections on glass slides were stained with Hematoxylin & Eosin
(H&E; Core Lab Facility, Department of Anatomy, LSUHSC-
Shreveport, LA) and a glass cover-slip applied with Permount
(Fisher Scientiﬁc). Cytologies and histopathologies were deter-
mined microscopically using an Olympus BX43F light microscope
(Tokyo, Japan) as described previously (Langford et al., 2002, 2006).
Digital images were created using Olympus Soft Imaging Solutions
(CellSons Life Science Imaging Software, Münster, Germany).
2.9. Immunoﬂuorescent antibody detection of GGT/CRT-positive
cells
Immunoﬂuorescent antibody (IFA) detection of immunoreactive
GGT and CRT in the tear cell inﬁltrate was performed using the
previously described methods (Burnham et al., 2013; Chen et al.,
2005). Brieﬂy, the nucleic acid stain DAPI (40,6-diamidino-2-
phenylindole) (Sigma, St. Louis, MO) in PBS was reacted with the
air-dried, ethanol ﬁxed, tear cells on glass slide for 1 h (per the
manufacturer’s recommendation). The slides were rinsed in 3 times
in fresh PBS. Murine monoclonal antibody to GGT (1:1000; Cat No.
53506; Ana Spec, Inc., Fremont, CA) and chicken IgY antibody to
CRT synthetic peptide (PA1-903; Thermo Scientiﬁc/Pierce
Biotechnology, Rockford, IL) were applied and incubated overnight
at 4 C. The unbound primary antibodies were removed and the
slides rinsed 3 times in PBS. The cells were reacted with tetrame-
thylrhodamine isothiocyanate (TRITC)-labeled F(ab0)2 fragment of
goat anti-mouse IgG and ﬂuorescein isothiocyanate (FITC)-labeled
donkey anti-chicken IgY (1:1000 dilution in PBS; Jackson Immu-
noResearch Laboratories, Inc., West Grove, PA). All IFA procedures
and digital color images were generated as previously described
(Burnham et al., 2013; Langford et al., 2010). Multiple color images
were merged using Scanalytics IPLab 3.7 software.
2.10. Statistical analysis
Graphs and statistical analyses of differences between rabbit
groups and eyes were determined using Microsoft Excel software
(Microsoft, Seattle, WA) or Sigma Plot for Windows 11.1 software
(Systat Software, Inc., Chicago, IL). Differences between eye pairs
and rabbit groups were considered signiﬁcant for p-value < 0.05
obtained by paired and unpaired student t-tests, respectively.
3. Results
3.1. Experimental pyogenic conjunctivitis/iritis (PCI)
Topical application of MDP to one eye induced bilateral PCI in
both eyes (Fig. 1). Symptoms, especially the amount of chemosis
and exudate, varied between eyes and rabbits, but generally
increased through 6e7 h. The inﬂammatory changes in the MDP-
treated eyes were characterized by rapid onset (3 h) of tearing,
redness, lid edema, and chemosis (i.e., diapiresis in the superior and
inferior palpebral conjunctival tissue), watery converting to
mucopurulent discharge, and iritis (iris erythema, aqueous ﬂare,
dilation of iris vessels) without cellular inﬁltrate (Fig. 1A). Similar,
but milder symptoms were detected after an hour delay in the
Fig. 1. Clinical symptoms and cytopathology. (A) Appearance of MDP-treated rabbit eyes at 3 and 7 h after topical application. Note the progression over time and the variability in
the iritis, conjunctival chemosis (arrows) and mucopurulent exudates (*) between rabbits 1 and 2. (B) Appearance of ipsilateral control eyes at 0, 4, 6 and 7 h.
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the ipsilateral eyes were generally associated with more severe
symptoms in the MDP-treated eyes. The bilateral PCI resolved
completely in most rabbits over 48 h.
3.2. Clinical course
The clinical symptoms of hyperemia, chemosis, exudate and iritis
were detected by 4 h post topical application in the MDP-treated
eyes. Clinical scores were maximal by 5e6 h (scores of 2e3 for
each symptom), remained through 8 h, and declined by 12 h
(Fig. 2A). Generally, the PCI resolved by 24 h, but signs of conjunctival
redness and lid edemawere detected up to 48 h in some rabbit eyes.
The onset of clinical symptoms in the mock-treated contralateral eye
lagged behind the MDP-treated eye by 1e2 h (Fig. 2B). Peak clinical
scores were lower in the mock-treated contralateral eyes (5.5 versus
10 in the MDP-treated eyes) than in the ipsilateral eyes. The cumu-
lative clinical scores (sum of average score for all symptoms at a time
point) were greatest 5e8 h post application for the ipsilateral and
mock-treated contralateral eyes. Nomembranes, pseudomembranes,
follicles, papillae, preauricular lymphadenopathy, corneal involve-
ment, mydriasis or cells in AH were detected.
3.3. MDP levels in tears and serum
High MDP levels were detected in tear (103.70.5 CD50/mL) be-
tween 0.25 and 1.0 h in treated eyes of 6 rabbits. MDP levels
declined to undetectable levels (<1.0 CD50/mL) by 6 h in tears of the
MDP treated eyes. MDP was not detected in tears of the mock-
treated contralateral eyes (Fig. 3). Serum MDP levels were
101.20.2 CD50/mL at 0.25 h and 100.50.48 CD50/mL at 1.0 h post
application and declined to undetectable levels by 2 h. Note that
MDP declined as bilateral PCI symptoms reached near maximal
levels.
3.4. Conjunctival pathology
Histopathological changes consistent with chemosis (ﬂuid
accumulation in the interstitial spaces beneath the conjunctivalepithelium) and leukocytic inﬁltrationwere less prominent in cryo-
sections of ipsilateral (Fig. 4A) than MDP-treated (Fig. 4B) eyes at
5 h. Muco-proteinaceous strands with cells were detectable in of
MDP-treated eyes (Fig. 4B). Fewer gross changes (i.e., enlarged
interstitial spaces) were detected in the palpebral conjunctiva of
the mock-treated contralateral eye at 5 h (Fig. 4A). The conjunctival
tissues from the ipsilateral eyes at 5 h were similar to the untreated
control rabbit eyes (not shown). H&E staining of parafﬁn-
embedded conjunctival tissue from ipsilateral (Fig. 4C) and MDP-
treated (Fig. 4D) eyes identiﬁed more heterophils between and
beneath the basal epithelial cells and in the lamina propria inter-
stitial spaces of palpebral conjunctival tissue ofMDP-treated eyes at
5 h. Notably, heterophils were detected between conjunctival
epithelial cells and in the dilated conjunctival venous capillaries in
the ipsilateral eyes (Fig. 4E) at 6 h post. Small (Fig. 4F) and broad
breaches (Fig. 4G) in the conjunctival epithelium with emerging
heterophils were detected within the conjunctival epithelium of
MDP-treated eyes at 6 h. Dilation of the iris and ciliary body
vasculature, but without cell ﬁltrate in the anterior chamber, was
detectable at 6 h (not shown). The conjunctival histopathologies
were consistent with bilateral clinical signs and symptoms of
vascular dilation, chemosis, and mucopurulent pyogenic exudates.3.5. Effect of topical MDP on tear production
Bilateral Schirmer tear tests were performed pre and post
topical MDP application in 22 rabbits to measure changes in tear
production (Fig. 5). Tear production increased above pre-treatment
levels in the MDP-treated and mock-treated contralateral eyes
(14  7 and 17.3  3.3 mm/5 min, respectively) between 2 and 7 h
(all p-values  0.04), but returned to near pre-treatment levels by
24 h. Tear production was signiﬁcantly greater in the ipsilateral
eyes than in the mock-treated contralateral eyes only at 6 h
(p ¼ 0.02). The mean (SEM) tear production was signiﬁcantly
higher in the MDP-treated eyes (24.9  1.1 mm/5 min) than in the
mock-treated contralateral eyes (20.7  1.9 mm/5 min; p < 0.0001)
between 2 and 12 h. The results support acute bilateral increases in
tear production with greater tear production in MDP-treated than
in mock-treated contralateral eyes.
03
6
9
12
15
0
 
h
1
 
h
2
 
h
3
 
h
4
 
h
5
 
h
6
 
h
8
 
h
1
2
 
h
2
4
 
h
4
8
 
h
Time Post MDP
C
l
i
n
i
c
a
l
 
S
c
o
r
e
 
Hyperemia
Chemosis
Iritis
Exudate
`Total
0
3
6
9
12
15
0
 
h
1
 
h
2
 
h
3
 
h
4
 
h
5
 
h
6
 
h
8
 
h
1
2
 
h
2
4
 
h
4
8
 
h
Time Post MDP
C
l
i
n
i
c
a
l
 
S
c
o
r
e
Hyperemia
Chemosis
Iritis
Exudate
Total
*
A. B.
Fig. 2. Clinical course of the MDP-induced bilateral conjunctivitis/iritis. Average scores for clinical symptoms in (A) MDP-treated and (B) contralateral eyes for 4 rabbits. Cumulative
clinical scores (bold line) is the sum of average clinical score for all symptoms.
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The tear and AH protein concentrations were determined in the
MDP-treated and mock-treated contralateral control eyes to iden-
tify MDP-induced blood-conjunctival (BCB) and blood-aqueous
barrier (BAB) permeability changes. Tear protein concentrations
were increased in both eyes through 6 h and were signiﬁcantly
higher (p-values  0.01) in MDP-treated than in the mock-treated
contralateral control eyes between 3 and 7 h (Fig. 6A). Tear pro-
tein concentrations declined to near pre-treatment levels by 12 h.
Concomitantly, the PAGE protein proﬁles for bilateral tear samples
were consistent with a 1e2 h lag period between the pronounced
BCB disruption in the MDP-treated eyes (Fig. 4) and supported
increased BCB permeability in the mock-treated contralateral eyes
(Fig. 6B). Accordingly, albumin (68 kDa protein) levels were
elevated in the tears of MDP-treated eyes through 6 h and in the
mock-treated contralateral eyes through 8 h consistent with theTime Post MDP
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Fig. 3. MDP quantiﬁcation. Ipsilateral tear and serum MDP levels (mean  SEM) were
elevated after unilateral topical application in 6 rabbits.respective bilateral increase in total tear protein. Several protein
bands unique to MDP-treated eyes were present in tears collected
at 4e8 h; supporting histopathological differences between eyes.
The AH protein concentrations were 3.7 times higher at 8 h inMDP-
treated eyes (3.45  0.7 mg/mL) than in mock-treated contralateral
eyes (0.94  0.37 mg/mL; n ¼ 4; p ¼ 0.0008), 10 times higher than
in AH from untreated adult rabbit eyes (0.33  0.09 mg/mL;
p ¼ 0.0001), but lower than in serum (7.93  0.85 mg/mL;
p ¼ 0.0002) (Fig. 6C). PAGE AH protein analysis supported promi-
nent albumin extravasation into the AH and higher protein con-
centrations in AH of MDP-treated than in mock-treated
contralateral eyes at 8 h (Fig. 6D). Taken together, the results sup-
port bilateral increases in tear and AH protein levels and suggest
the relative increase in BCB and BAB permeability was MDP-
treated > mock-treated contralateral > untreated eyes. The higher
levels and diversity of ipsilateral tear protein were likely due to a
combination of transudate due to vascular leakage, exudate due to
permeabilization epithelium, and release of proteins into tear by
the cellular inﬁltrate.3.7. Effect of topical MDP-treatment on tear ﬂuid, Schirmer strip
and AH GGT activity
GGT levels were investigated in cell-free tear ﬂuids (inﬁltrating
cells removed), Schirmer test strips (adsorbed tear ﬂuid, proteins
and cells), AH and sera to determine the relationship between the
tear GGT, edemagenic (chemosis) and pyogenic responses induced
by topical MDP application. Over the course of the bilateral
conjunctivitis/iritis, elevated tear GGT activities were detected ﬁrst
in the ipsilateral eyes (peaking at 4e5 h) followed closely by
elevated levels in the mock-treated contralateral eye (peaking at 6e
8 h). Post treatment tear GGT activities (2e8 h) were consistently
higher (up to 10-fold) in tear ﬂuids of ipsilateral and mock-treated
contralateral eyes than in untreated placebo-control rabbit eyes (p-
values  0.01) (Fig. 7A). The GGT activity levels were signiﬁcantly
higher (p-values  0.001) in tear ﬂuids from ipsilateral eyes than
from mock-treated contralateral eyes at 3e5 h. Bilateral tear ﬂuid
GGT activity declined to near pre-treatment levels by 12 h. Simi-
larly, Schirmer test strip GGT activity was detected ﬁrst in the MDP-
treated eyes and was signiﬁcantly higher in MDP-treated eyes than
mock-treated contralateral eyes at 3 and 4 h (Fig. 7B). Post treat-
ment Schirmer test strips GGT activity was signiﬁcantly higher in
the MDP-treated and contralateral eyes than in untreated placebo-
Fig. 4. H&E staining of cryo-sections of rabbit conjunctival tissues from the (A) ipsilateral and (B) MDP-treated eyes of a rabbit at 5 h. Note the proteinaceous exudate and leukocytic
inﬁltration in the MDP-treated eye. H&E staining of parafﬁn-embedded conjunctival tissue sections from (C) ipsilateral and (D) MDP-treated eyes at 5 h. Note the dilation of the
subconjunctival blood vessels and numerous heterophils in the conjunctival vein (large arrow) and epithelium of the MDP-treated eye (small arrow). H&E of parafﬁn-embedded
conjunctival tissue of the (E) ipsilateral and (F) MDP-treated eye at 6 h showing numerous heterophilic leukocytes (small arrows) in the superior palpebral conjunctival epithelium
of the ipsilateral eye and the extravasation of heterophils and detached palpebral conjunctival epithelial cells in the MDP-treated eye. (G) MDP-treated rabbit eye at 6 h showing
numerous heterophils associated with an area of disrupted superior bulbar conjunctival epithelium. [Bar ¼ 50 mm].
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Schirmer test tear GGT activities were elevated above untreated
placebo-control rabbit tear levels at 24 h. [Note: Tear GGT activity
per Schirmer strip did not correlate with tear volume/strip (datanot shown).] Notably, the GGT activity levels in pre-treatment cell-
free tear (6.2 4.6 U/mL; p< 0.0001) were lower than in untreated
adult rabbit sera (31.6  6.4 U/mL). GGT activity levels were 2e5-
fold higher in bilateral cell-free tears collected 3e8 h post MDP
M.P. Langford et al. / Experimental Eye Research 116 (2013) 324e336330treatment (70e150 U/mL; p-values  0.01) than in serum
(Fig. 7A&C) suggesting a local GGT source. The post mortem AHGGT
activity levels were 2-fold higher in ipsilateral eyes (17.4  4.7 U/
mL) than in the AH of the mock-treated eyes (8.3  1.9 U/mL;
p ¼ 0.001) of rabbits euthanized at 8 h. GGT levels were higher in
the ipsilateral and mock-treated contralateral eye AH than in un-
treated control eye AH (3.2  2.5 U/mL; p ¼ <0.0001; p ¼ 0.003,
respectively) (Fig. 7C), but 45% lower than in serum (p < 0.0001)
consistent with the apparent diapiresis of serum GGT into bilateral
AH. The results support a temporal lag between the tear GGT ac-
tivity responses of the ipsilateral and mock-treated contralateral
eyes, and a 10-fold increase in bilateral tears and AH GGT activity
levels above the levels in tear and AH of untreated control rabbits.
The results suggest that tear GGT activity in untreated rabbits was
elevated slightly in response to tear collection, that bilateral GGT
activity levels in tears of inﬂamed eyes were due to cell-free and
cell-associated GGT, and that elevated AH GGT activity was likely
due to increased permeability of the BAB to serum GGT.
3.8. Bilateral cellular responses and tear cell GGT/CRT
immunoreactivity
Cell densities, H&E cytology, and immunoreactivity of the
cellular inﬁltrate in tear with antibody to GGT (neutrophil marker)
and CRT (MDP-binding protein) were determined in bilateral tears
collected over the clinical course to characterize the cellular re-
sponses induced by topical MDP. Higher cell numbers were
detected in tears from ipsilateral than the contralateral eyes (Fig. 8).
Tear cell density increased to maximal levels in the MDP-treated
(5.02  0.98  106 cells/mL) and mock-treated contralateral
(2.70  1.04 106 cells/mL) eyes through 8 h, then declined to near
pre-treatment levels by 24 h (Fig. 8A). Higher cell densities were
signiﬁcant only at 2, 3, 7, and 8 h (p-values  0.01). Tear samples
collected at 2 and 3 h from ipsilateral eyes contained primarily
epithelial cells with few leukocytes (not shown) consistent with
early conjunctival cytopathology. Epithelial cells, leukocytes and
cell debris were detected in tears from MDP-treated and mock-
treated-treated eyes collected between 3 and 8 h, but heterophilsTime Post MDP
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Fig. 5. Tear production. Bilateral tear production by 22 rabbits post-unilateral topical
MDP. Each point represents the mean mm (standard deviation; S.D.) of tear adsorbed
in 5 min to Schirmer’s test strips placed in unanesthetized eyes. Asterisk (*) indicates a
signiﬁcant difference in tear production between MDP-treated and contralateral eyes
at 6 h (p ¼ 0.02). Bar indicates signiﬁcantly higher levels of consensual MDP-treated
and contralateral eye tear production above the levels of pre-treatment tear produc-
tion (p-values  0.04).were predominant in tears collected between 5 and 12 h (Fig. 8B).
The results of the tear immunoﬂuorescent antibody analysis
(Fig. 8CeF) suggested that the heterophils, macrophages or
conjunctival epithelial cells were positive for extrinsic GGT
(Fig. 8D). Also, some heterophils andmacrophageswere positive for
surface CRT (Fig. 8E). Notably, strong surface CRT and GGT immu-
noreactivity was co-localized between heterophils and between
heterophils and macrophages or conjunctival cells in tears (Fig. 8F).
Together, the results suggest that the elevated GGT activity in
clariﬁed bilateral tear ﬂuids collected post topical MDP application
was due to release of GGT from GGT-positive cells in the tear ﬂuid
and increased permeability of the BCB to serum GGT. Concomi-
tantly, the increase in Schirmer tear GGT activity was due to free
GGT in tear and serum exudate, but was predominantly due to GGT-
positive conjunctival/leukocytic cell adsorbed to the test strip.
3.9. Bilateral tear GGT responses to repeat unilateral topical MDP
applications
Since the results suggested that Schirmer test tear GGT activity
is temporally and quantitatively associated with the GGT-positive
leukocytic inﬁltration (pyogenic conjunctivitis) induced by topical
MDP, tear GGTactivity levels on Schirmer test strips were utilized to
monitor changes in the inﬂammatory responses to repeat topical
MDP applications in 3 rabbits. The bilateral clinical courses (i.e.,
exacerbation and resolution of bilateral conjunctivitis/iritis) and
GGT responses were recurrent after each unilateral MDP applica-
tion (Fig. 9). The tear GGT activity was 2e10-fold higher at 2, 4, 6,
and 8 h post MDP application in the ipsilateral eyes than in the
mock-treated contralateral eyes over the 16 d course. Notably, the
average levels (256  13 U/strip) of Schirmer tear GGT activity in
the ipsilateral eyes at 4, 6, and 8 h after the ﬁrst MDP application
were signiﬁcantly greater than the average Schirmer tear GGT ac-
tivity of the ipsilateral eyes at 4, 6 and 8 h for the 5 subsequent
MDP-applications (72  14; 129  37, 185  18, 144  67 and
204  5 U/Strip; p’s ¼ 0.0001, 0.004, 0.004, 0.04, and 0.003,
respectively). In the mock-treated contralateral eyes, the average
levels (84  31 U/strip) of Schirmer tear GGT activity at 4, 6 and 8 h
after the initial application were generally lower than in Schirmer
test tear GGT activities after 5 repeat MDP applications (33  13,
38  29, 36  29, 25  6, and 40  29 U/strip, respectively), but
were not signiﬁcantly different except for the 4th cycle (p ¼ 0.03).
The results suggest GGT responses were greater in the MDP-treated
eyes, decreased with repeat application in the MDP-treated eyes,
but were similar in the mock-treated contralateral eyes after repeat
unilateral topical MDP applications.
4. Discussion
Acute onset transient bilateral pyogenic conjunctivitis/iritis
(PCI) was induced in adult rabbits by unilateral topical application
of the bacterial cell wall peptidoglycan MDP. The PCI occurred ﬁrst
in theMDP-treated eyes and was followedwithin 1e2 h by amilder
PCI in the mock-treated contralateral eye. The MDP-induced PCI
exhibited similar clinical signs, symptoms and course as acute
bacterial conjunctivitis in man being characterized by acute onset
of tearing, lid edema, conjunctival erythema, chemosis, and
mucopurulent discharge. In addition, an acute bilateral transient
acute iritis (without AH cells) was observed with the edemagenic
changes. No corneal involvement, follicles, papillae andmembranes
were detected. Most symptoms of the bilateral PCI resolved in most
rabbits by 48 h.
The acute onset of tearing and inﬂammatory changes in the
conjunctiva and iris by 4 h in the ipsilateral eye suggests topical
MDP application caused the PCI. The dissociation and disruption of
Fig. 6. Tear and aqueous humor (AH) protein. (A) Mean protein concentrations (SD) in tear samples from MDP-treated and contralateral control eyes of 6 rabbits (*; p-
values  0.01). (B) Protein proﬁles of tear samples (3 ml/lane) collected from MDP-treated and contralateral control eyes of one rabbit. Note the increase in the 68 kDa albumin
protein band (arrow) in tears of both eyes and the increase of several 40e70 kDa proteins in the tear ﬂuid from MDP-treated at 4e8 h. (C) Protein concentrations in MDP-treated,
mock-treated contralateral (CLat) and untreated (UnTx) AH collected from rabbits at 8 h post treatment were signiﬁcantly different from each other and from serum (*; p-
values  0.005). (D) The protein proﬁle (5 ml/lane) of AH collected at 8 h post mortem from MDP-treated and contralateral control eyes of 4 rabbits.
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observed in the ciliary body epithelium observed in ipsilateral
rabbit eyes at 4 h post intracameral MDP injection (Langford et al.,
2006). Notably, the conjunctival epithelial cells/debris (consistent
with cytopathology), increased levels of cell-free tear GGT activity
(consistent with release of GGT), and elevated tear and AH protein
levels (consistent with increased permeability of the BCB and BAB)
were greater in the ipsilateral eyes than in the mock-treated
contralateral and untreated rabbit eyes. Thus, these results sug-
gest that the cytopathologies in the ipsilateral conjunctiva and iris
were likely due to the direct cytotoxic effect of MDP and/or pro-
inﬂammatory mediators induced by the interaction of MDP with
leukocytes, epithelium, vascular endothelium, and neuronal cells
(Adam et al., 1981; Johannsen et al., 1991; Oppenheim et al., 1980;
Zídek et al., 1993). Accordingly, the bilateral conjunctival erythema,
chemosis, and elevated tear proteins were associated with histo-
pathological changes in the conjunctival vasculature (BCB) and
epithelium (BTB) of the MDP-treated eyes, while the iris erythema,
aqueous ﬂare and elevated AH proteins were consistent with theBAB disruption observed post intravenous MDP (Kufoy et al., 1990;
Lawrence et al., 1992; Waters et al., 1986).
The PCI in the MDP-treated eyes preceded the onset of milder
PCI in the mock-treated contralateral eye by 1e2 h. The sequential
onset of inﬂammation and asymmetric bilateral involvement of the
conjunctiva and iris following topical MDP application was similar
to the bilateral responses previously noted following unilateral
MDP administration (Langford et al., 2003, 2006). The possibility of
hematogenous spread to the fellow eye is suggested byMDP’s small
size and detection in serum. The rapid removal of MDP via the
lacrimal duct of the ipsilateral eye and rapid decline in serum MDP
levels suggests limited tissue exposure and a milder dose-
dependent response in the fellow eye. However, the inability to
detect MDP (<1 CD50; i.e., <5 ng/mL) in mock-treated contralateral
tears argues against hematogenous spread. Also, the absence of
conjunctival cells/debris in the tears of the fellow eyes suggests the
BCB of the mock-treated contralateral eye may have limited the
spread of MDP to the extraocular surface. Thus, the changes
observed in conjunctival and iris tissue of the mock-treated
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Fig. 7. GGT levels in tear and aqueous humor (AH) post topical MDP. (A) GGT activity
was signiﬁcantly higher in cell-free tear ﬂuid collected from 6 MDP-treated eyes at 3e
5 h than in mock-treated contralateral eyes (*; p-values < 0.01; unpaired t-test), but
the GGT activity post 2 h was signiﬁcantly lower in bilateral cell-free tear ﬂuids from
untreated control rabbit eyes (p-values < 0.001). (B) Signiﬁcantly higher GGT activity
per Schirmer test strip was detected at 3 and 4 h in 6 MDP-treated eyes than in mock-
treated contralateral eyes, but GGT activity on Schirmer test strips from the untreated
control rabbit eyes was signiﬁcantly lower (*; p-values  0.05). (C) Signiﬁcantly higher
levels of GGT activity were detected in AH collected from MDP-treated and mock-
treated contralateral (CLat) eyes of 4 rabbits euthanized at 8 h post topical MDP
treatment than in AH and serum of 3 untreated (UnTx) control adult rabbits.
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release of chemical mediators from the inﬂamed eye (Chiang and
Thomas, 1972) and/or a neuronal response (Perkins, 1957).
Accordingly, the interactions between the MDP applied to
conjunctival epithelial cells and/or lymphoid cells associated with
the conjunctival and iris tissue could produce pro-inﬂammatory
mediators, such as prostaglandins, interleukin-1b (IL-1b), and tu-
mor necrosis factor-a (TNF-a) (Cottagnoud et al., 2003; Langford
et al., 2002, 2011; Nagao et al., 1981; Oppenheim et al., 1980;
Waters et al., 1986). These chemical mediators could spread to
the contralateral eye producing the increased permeability of
intraocular blood-barriers in a manner similar to the responses
reported in the contralateral eyes post intracameral prostaglandin
injection, cataract surgery, and ultraviolet light exposure (Beitch
and Eakins, 1969; Podos, 1976; Miyake et al., 1984; Meyer et al.,
2013; Shah and Spalton, 1994). The likelihood that topical MDP
could induce cytotoxicity and bilateral conjunctivitis with pyogenic
discharge, iritis and AH protein mediated bymacrophage activation
and/or endogenous prostaglandin is supported by its pharmaco-
logical properties, endogenous production (Fleisher et al., 1992;
Nagao et al., 1990; Podos, 1976; Langford et al., 1999, 2006) and is
suggested by indomethacin’s inhibition of MDP-induced uveitis,
edema, and apoptosis (Langford et al., 2002; Waters et al., 1986;
Zídek et al., 1993). However, the possibility that other mediators
or mechanisms cannot be ruled out. In this regard, it should be
noted that the increased permeability of the human BAB in
contralateral eyes post implant surgery was not inhibited by
indomethacin (Miyake et al., 1984). Further, MDP application may
induce an alteration in the neuronal reﬂex in the contralateral eye
(Leplat, 1924) that could account for the increased tearing and
vascular permeability in the conjunctiva and iris of the fellow eye;
possibly via binding to serotonin binding sites (Polanski et al., 1995;
Root-Bernstein and Westall, 1990; Sevcík and Masek, 1999). Addi-
tional studies are needed to detect potential mediators and delin-
eate the mechanism(s) responsible for the putative consensual
response.
Elevated GGT activity levels paralleled the respective cellular
increases in the tears and occurred earlier and higher in ipsilateral
eyes than in contralateral eyes. The elevated bilateral tear GGT ac-
tivity between 4 and 8 h was associated with GGT-positive het-
erophils/macrophages and was consistent with GGT as a marker for
an innate inﬂammatory response (Corti et al., 2012; Singh et al.,
1986). Notably, the bilateral acute heterophilic tear inﬁltrate
shares some aspects with the neutrophilic sequestration reported
with sepsis (Toft et al., 1993), LPS (Erzurum et al., 1992), interferon
(Urbaniak et al., 1978), and TNF-a/IL-1b injection (Fleisher et al.,
1992). Moreover, acute transient leucopenia has been reported
post-intravenous MDP injection (Kotani et al., 1976; Waters et al.,
1986). The absence of a detectable leukocytic inﬁltrate in the post
mortem AH of our rabbit eyes with PCI, as well as in rabbits with
MDP-induced uveitis was thought to be to immune privilege
(Lawrence et al., 1992). Clearly, the bilateral GGT/cellular responses
induced by topical MDP were greater than the responses induced
by Schirmer test application and/or eye manipulation. Moreover,
the inﬂammatory responses in the contralateral eyes of rabbits
treated topically with MDP were more acute, more transient and
less severe than the responses reported in the contralateral post
monocular trauma (Li et al., 1994), ultra-violet light exposure
(Meyer et al., 2013), HSV-1 infection (Atherton et al., 1987), bacte-
rial infection (McCormick et al., 2011), topical LPS (Schultz et al.,
1997) and intravitreal peptidoglycan injection (Rosenzweig et al.,
2011) supporting an acute innate immune response rather than
an adaptive immune response.
The inﬁltration of heterophils may be to removeMDP, a toileting
response to damaged cells and/or contribute to the conjunctival
Fig. 8. Tear cytology. (A) Tear cell density (cells/1.0 mL) in MDP-treated and mock-treated contralateral control eyes at times post MDP application. (Each point is the average number
of cells in tears of 3 rabbits; *; p < 0.05). (B) Tear sample collected at 5 h from a MDP-treated eye showing numerous band and segmented heterophils (PMN), with eosinophils,
macrophages (arrow) and epithelial cells (*) (H&E). (CeF) Triple labeling for nuclei (blue), CRT- (green) and GGT- (red) positive cells in tear collected at 6 h from a MDP-treated eye.
(C) Strong DAPI-positive (blue) heterophils (arrowheads) and weakly DAPI-positive presumed macrophages or epithelial cells (arrows). (D) Extrinsic GGT expression was detected
on and between heterophils and macrophages/epithelial cells. (E) Cell-surface CRT was expressed on heterophils and macrophages. (F) The merged image shows areas of surface
CRT co-localized with surface GGT between heterophils and/or macrophages (*). (Bar ¼ 50 mm).
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Fig. 9. Repeat unilateral MDP application. Bilateral Schirmer tear GGT activity levels after repeat unilateral topical MDP applications over the course of 16 days. Each point is the
average GGT activity on Schirmer test strips from MDP-treated and contralateral untreated eyes of 3 rabbits. Arrows indicate times of topical MDP application.
M.P. Langford et al. / Experimental Eye Research 116 (2013) 324e336334cytopathology (Gaynor, 1973; Trinkaus-Randall et al., 1991). The
decline in tear MDP coincided with the appearance of CRT-positive
heterophils suggests MDP clearance by binding to CRT-positive
heterophils. MDP binding to CRT on inﬁltrating leukocytes and
conjunctiva-associated cells could affect intracellular calcium ho-
meostasis, cellular stress responses, and innate immunity (Wang
et al., 2012; Zeng et al., 2006) and/or induce caspase-mediated
apoptosis with activation of IL-1b (Langford et al., 2011). The
absence of chronic clinical symptoms after repeat MDP applications
may be taken to argue against heterophilic cytopathology. More-
over, surface GGT and CRT were co-localized on the cell surface
between tear heterophils and macrophages and conjunctival cells
consistent with efferocytosis. That is, CRT expression by human
PMN facilitates phagocytosis of live and apoptotic cells (Gardai
et al., 2005; Thorp et al., 2011). Concomitantly, the function of the
GGT activity in inﬂamed tear is unknown, but GGT is expressed by
neutrophils, macrophages and conjunctival cells (Burnham et al.,
2013; Coupland et al., 1993; Gukasyan et al., 2003) and is impor-
tant to recapture of glutathione, the neutrophil response and res-
olution of inﬂammation (Carlisle et al., 2003; Grisk et al., 1993;
Kobayashi et al., 2003). Additional studies are needed to ascertain
the role of GGT/CRT-positive heterophils in this adult rabbit model
of aseptic PCI.
The course of the recurrent bilateral acute conjunctivitis/iritis
and Schirmer test tear GGT activity cycles produced following
repeat topical MDP applications were temporally similar with
resolution within 24 h. The recurrent PCI cycles were similar to the
transient anterior uveitis cycles induced by repeat intravenous
MDP injections (Li et al., 1993). However, GGT/cellular responses to
subsequent topical MDP applications were less intense in the
ipsilateral eyes, were similar in the contralateral eyes, and did not
cause gross conjunctival pathologies. Cytopathological changes
and/or chronic inﬂammatory disease in uveal, lung, joint, and in-
testinal tissues have been reported post repeat MDP applications
over a more extended period (Gardner et al., 1991; Kuroe et al.,
1996; Li et al., 1993; Richerson et al., 1982). The transient PCI
course and resolution without sequelae likely depends on rapid
MDP elimination.
Taken together, the results show topical application of MDP
induces bilateral PCI in adult rabbits and suggest MDP-inducedcytotoxicity/immunostimulation should be considered in persons
with bilateral PCI of unknown etiology, particularly in the elderly
with renal and/or lacrimal dysfunction (i.e., decreased capacity to
eliminateMDP) and occult bacterial infection (increased capacity to
generate MDP). The detection of GGT/CRT-positive rabbit hetero-
phils in tears supports in vivo efferocytosis in eyes with MDP-
induced pyogenic conjunctivitis. This reproducible rabbit model
with tear GGT monitoring may be useful in investigating anti-
inﬂammatory agents in the treatment of MDP-induced PCI.Acknowledgments
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